It’s not just about eating plants—it’s about choosing whole, unprocessed plants like beans and whole grains over sugary snacks and white bread, as the former are linked to longer life and the latter to shorter life.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A meta-analysis could determine whether the differential mortality risk between healthful and unhealthful plant foods is reproducible across diverse populations and dietary assessment tools.
A systematic review and meta-analysis of at least 15 prospective cohort studies using validated hPDI and uPDI indices, reporting HRs for all-cause mortality by quintile, with subgroup analyses by region, income level, and baseline health status.
An RCT could test whether replacing unhealthful plant foods with healthful ones reduces mortality risk, isolating the effect of food quality.
A 15-year RCT of 3,000 adults aged 50–65 with suboptimal diets, randomized to either a diet replacing refined grains and sugary drinks with whole grains, legumes, and nuts (hPDI-focused) or a control diet, with mortality as the primary endpoint and dietary adherence monitored via biomarkers and food logs.
A new cohort study could confirm whether changes in hPDI/uPDI scores over time predict changes in mortality risk.
A prospective cohort of 15,000 adults aged 40–70, with dietary intake assessed every 3 years using validated FFQs, calculating hPDI and uPDI scores longitudinally, and linking to national death registries over 20 years, adjusting for time-varying confounders.
A case-control study could compare past dietary patterns of individuals who died from any cause with survivors, focusing on whether uPDI was higher among decedents.
A matched case-control study of 1,500 individuals who died from any cause before age 75 and 1,500 age- and sex-matched survivors, assessing dietary intake via validated FFQs for the 10 years prior to death or enrollment, with focus on hPDI and uPDI components.
A cross-sectional study could show whether individuals with high uPDI scores have higher levels of inflammation, insulin resistance, or other biomarkers linked to mortality.
A cross-sectional analysis of 8,000 adults measuring hPDI and uPDI scores alongside biomarkers (CRP, fasting glucose, HOMA-IR, LDL, triglycerides) in a single visit, adjusting for age, sex, BMI, and physical activity, to assess if uPDI correlates with metabolic dysfunction.